Structure Therapeutics Ownership | Who Owns Structure Therapeutics?
Structure Therapeutics Ownership Summary
Structure Therapeutics is owned by 38.39% institutional investors, 4.83% insiders, and 56.78% retail investors.
GPCR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Structure Therapeutics | 38.39% | 4.83% | 56.78% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 184 | 4.55% | 60,629,867 | -1.30% | 38 | 2.54% | 94 | -2.08% | 49 | 28.95% |
Sep 30, 2024 | 176 | -9.28% | 61,427,326 | 3.62% | 38 | 21.50% | 96 | -22.58% | 38 | -2.56% |
Jun 30, 2024 | 194 | 34.72% | 59,282,748 | 35.85% | 13 | 13.72% | 124 | 61.04% | 39 | 8.33% |
Mar 31, 2024 | 144 | 4.35% | 43,639,591 | 2.47% | 9 | 10.61% | 77 | -16.30% | 36 | 44.00% |
Dec 31, 2023 | 138 | 64.29% | 42,586,081 | 29.86% | 9 | 18.99% | 92 | 29.58% | 25 | 316.67% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 06, 2025 | FMR LLC | See Remark 1 | Sell | - |
Jun 10, 2024 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Sell | - |
Jun 03, 2024 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | - |
Jun 03, 2024 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | - |
Mar 14, 2024 | FMR LLC | See Remark 1 | Sell | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | - | 3 |
2024 Q1 | - | 2 |
2023 Q4 | - | 4 |
2023 Q3 | - | - |
GPCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools